Light Mode
$9.30 ↓ -0.03 (-0.32%) Trading Down from the previous close of $9.33
-24.26 (-72.22%) / 6M
Momentum, market sentiment, and recent alerts
STRO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +704.3%.
No alerts for STRO in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.